Marc Eid

8PUBLICATIONS
120CO-AUTHORS
Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 01, 2026
COVID-19 in Patients With Gynecologic Cancer: A Report From the COVID-19 and Cancer Consortium.

|Apr 20, 2026
Cell-free chromatin epigenomic profiling enables non-invasive pancreatic cancer cell-state identification.

|Jan 09, 2026
SNAP: Streamlined Nextflow Analysis Pipeline for Immunoprecipitation-Based Epigenomic Profiling of Circulating Chromatin.

Ze Zhang, Paulo Da Silva Cordeiro, Surya B Chhetri

|Jul 02, 2025
Tumor-Intrinsic and Microenvironmental Determinants of Impaired Antitumor Immunity in Chromophobe Renal Cell Carcinoma.

Chris Labaki, Eddy Saad, Katrine N Madsen

|Jun 27, 2025
International Medical Graduates Representation at International Oncology Conference Meetings: An Analysis of ASCO Annual Meetings.

Arya Mariam Roy, Ziad Bakouny, Nazli Dizman

|Feb 27, 2025
Assessing Clinical Value of New Treatment Strategies: ESMO-MCBS and ASCO-VF Evaluation in Phase III Trials at ASCO Annual Meeting 2022.

Sofie Seghers, Pablo Mandó, Marc Eid

Pageof 2

Frequent Collaborators

4 joint publications

Rashad Nawfal

4 joint publications

Toni K Choueiri

3 joint publications

Sylvan C Baca

3 joint publications

Marc Machaalani